Similar articles

• [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 May 12;147(19):49. MMW Fortschr Med. 2005. PMID: 15940939 German. No abstract available.
• Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.

  Abe M, Okada K, Matsumoto K. Abe M, et al. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1285-303. doi: 10.1517/17425250903282799. Expert Opin Drug Metab Toxicol. 2009. PMID: 19761411 Review.
• Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.

  Devereux RB, Dahlöf B. Devereux RB, et al. Curr Med Res Opin. 2007 Feb;23(2):443-57. doi: 10.1185/030079906X167435. Curr Med Res Opin. 2007. PMID: 17288698 Review.
• Losartan and hypertensive children. Another option for a small number of children.

  [No authors listed] [No authors listed] Prescrire Int. 2010 Aug;19(108):160. Prescrire Int. 2010. PMID: 20939445 No abstract available.
• Angiotensin II inhibition and prevention of atrial fibrillation and stroke.

  Bourassa MG. Bourassa MG. J Am Coll Cardiol. 2005 Mar 1;45(5):720-1. doi: 10.1016/j.jacc.2004.12.008. J Am Coll Cardiol. 2005. PMID: 15734616 No abstract available.